PT809512E - Solucoes farmaceuticas salinas nao inorganicas para administracao endonasal de uma calcitonina - Google Patents

Solucoes farmaceuticas salinas nao inorganicas para administracao endonasal de uma calcitonina

Info

Publication number
PT809512E
PT809512E PT96903969T PT96903969T PT809512E PT 809512 E PT809512 E PT 809512E PT 96903969 T PT96903969 T PT 96903969T PT 96903969 T PT96903969 T PT 96903969T PT 809512 E PT809512 E PT 809512E
Authority
PT
Portugal
Prior art keywords
calcitonin
endon
inorganic saline
pharmaceutical solutions
vasal
Prior art date
Application number
PT96903969T
Other languages
English (en)
Inventor
Paolo Alberto Veronesi
Anna Maria Veronesi
Emanuela Peschechera
Original Assignee
Therapicon Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapicon Srl filed Critical Therapicon Srl
Publication of PT809512E publication Critical patent/PT809512E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/585Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT96903969T 1995-02-08 1996-02-08 Solucoes farmaceuticas salinas nao inorganicas para administracao endonasal de uma calcitonina PT809512E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95101681A EP0726075A1 (en) 1995-02-08 1995-02-08 Pharmaceutical non-inorganic saline solutions for endonasal administration

Publications (1)

Publication Number Publication Date
PT809512E true PT809512E (pt) 2002-09-30

Family

ID=8218965

Family Applications (2)

Application Number Title Priority Date Filing Date
PT96903997T PT809654E (pt) 1995-02-08 1996-02-02 Analogos da calcitonina do salmao, sua preparacao, uso medicinal e uso como agentes amaliticos
PT96903969T PT809512E (pt) 1995-02-08 1996-02-08 Solucoes farmaceuticas salinas nao inorganicas para administracao endonasal de uma calcitonina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT96903997T PT809654E (pt) 1995-02-08 1996-02-02 Analogos da calcitonina do salmao, sua preparacao, uso medicinal e uso como agentes amaliticos

Country Status (17)

Country Link
US (2) US6087338A (pt)
EP (3) EP0726075A1 (pt)
JP (2) JPH11506416A (pt)
KR (2) KR100430101B1 (pt)
AT (2) ATE191719T1 (pt)
AU (2) AU4787996A (pt)
BR (1) BR9607410A (pt)
CA (2) CA2210664A1 (pt)
DE (4) DE726075T1 (pt)
ES (2) ES2146869T3 (pt)
GB (1) GB9523442D0 (pt)
HU (1) HUP9600266A3 (pt)
PE (1) PE28397A1 (pt)
PL (1) PL183398B1 (pt)
PT (2) PT809654E (pt)
WO (2) WO1996024618A1 (pt)
ZA (2) ZA96779B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
US6034064A (en) * 1995-04-07 2000-03-07 Hoechst Pharmaceuticals & Chemicals K.K. Peptides and therapeutic agent for autoimmune diseases containing the same
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
IT1298780B1 (it) * 1998-03-24 2000-02-02 Therapicon Srl Preparazioni parenterali a base di calcitonina
AU2001220765A1 (en) 2000-01-24 2001-07-31 Medtronic Minimed, Inc. Mixed buffer system for stabilizing polypeptide formulations
CA2399505C (en) 2000-02-04 2012-01-03 Unigene Laboratories, Inc. Nasal calcitonin formulations
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
JP4225416B2 (ja) * 2001-06-29 2009-02-18 旭化成ファーマ株式会社 タンパク質製剤の安定性を改善する方法
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
GB0422644D0 (en) * 2004-10-12 2004-11-10 Novartis Ag Organic compounds
EP1870458B1 (en) 2005-03-31 2018-05-09 Chugai Seiyaku Kabushiki Kaisha sc(Fv)2 STRUCTURAL ISOMERS
CN101262885B (zh) 2005-06-10 2015-04-01 中外制药株式会社 含有sc(Fv)2的药物组合物
KR101367544B1 (ko) * 2005-06-10 2014-02-26 추가이 세이야쿠 가부시키가이샤 메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용
CN100349611C (zh) * 2005-11-25 2007-11-21 中国药科大学 鲑降钙素吸入粉雾剂及其制备方法
AU2010206614B2 (en) * 2009-01-22 2015-03-26 Keybioscience Ag Treatment for obesity
KR102019911B1 (ko) 2011-11-02 2019-09-09 키바이오사이언스 아게 질병 및 장애 치료용 펩타이드 유사체
US9533022B2 (en) 2011-11-02 2017-01-03 KeyBioscience A/S Peptide analogs for treating diseases and disorders
WO2024189611A1 (en) * 2023-03-13 2024-09-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Stabilized analogues of calcitonin

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin
US4217268A (en) * 1978-07-20 1980-08-12 Hughes John L Synthesis of peptides
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4659804A (en) * 1984-11-01 1987-04-21 Armour Pharmaceutical Company (Bis-1,7-S-acetamidomethyl-L-cysteine)salmon calcitonin
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4622386A (en) * 1985-03-28 1986-11-11 Armour Pharmaceutical Company [1,7-di-alanine]calcitonin
US4639510A (en) * 1985-10-04 1987-01-27 Armour Pharmaceutical Company (1-S-acetamidomethyl cysteine, 7-alanine)calcitonin
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
DE3876022T2 (de) * 1987-07-08 1993-04-22 Mitsubishi Petrochemical Co Calcitonin-derivate und deren salze.
US5059587A (en) * 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
US5153308A (en) * 1988-06-16 1992-10-06 Teijin Limited S-sulfonated calcitonin derivatives
JPH0694851B2 (ja) * 1988-06-27 1994-11-24 株式会社日立製作所 蒸発燃料制御装置
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
JPH02104531A (ja) * 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
JPH0643339B2 (ja) * 1990-05-25 1994-06-08 旭化成工業株式会社 カルシトニン類水溶液組成物の安定化法
IT1248725B (it) * 1990-06-12 1995-01-26 Sclavo Spa Composizione farmaceutica in polvere per somministrazione per via nasale contenente essenzialmente calcitonina ed un eccipiente idrosolubile
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
IT1244500B (it) * 1991-03-21 1994-07-15 Pulitzer Italiana Impiego di sali minerali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via rettale in terapia umana
IT1251685B (it) * 1991-10-11 1995-05-19 Isf Spa Composizioni farmaceutiche contenenti una calcitonina
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
IT1255895B (it) * 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung

Also Published As

Publication number Publication date
KR19980702091A (ko) 1998-07-15
ZA96779B (en) 1996-08-29
US6087338A (en) 2000-07-11
EP0726075A1 (en) 1996-08-14
DE29622959U1 (de) 1998-03-05
CA2212520A1 (en) 1996-08-15
ATE191719T1 (de) 2000-04-15
HUP9600266A2 (en) 1997-06-30
KR100397034B1 (ko) 2003-11-13
JPH08245417A (ja) 1996-09-24
ZA96835B (en) 1996-08-19
EP0809512A1 (en) 1997-12-03
AU4787996A (en) 1996-08-27
EP0809654A1 (en) 1997-12-03
JP4123309B2 (ja) 2008-07-23
PT809654E (pt) 2000-10-31
DE69620393T2 (de) 2003-01-16
KR960030948A (ko) 1996-09-17
EP0809654B1 (en) 2000-04-12
DE726075T1 (de) 1996-12-12
CA2210664A1 (en) 1996-08-15
WO1996024618A1 (en) 1996-08-15
PL312683A1 (en) 1996-08-19
PL183398B1 (pl) 2002-06-28
DE69607749D1 (de) 2000-05-18
HUP9600266A3 (en) 2000-09-28
PE28397A1 (es) 1997-08-22
HU9600266D0 (en) 1996-04-29
GB9523442D0 (en) 1996-01-17
US6107277A (en) 2000-08-22
AU4786396A (en) 1996-08-27
EP0809512B1 (en) 2002-04-03
KR100430101B1 (ko) 2006-02-13
ES2173267T3 (es) 2002-10-16
DE69620393D1 (de) 2002-05-08
WO1996024370A1 (en) 1996-08-15
ES2146869T3 (es) 2000-08-16
ATE215381T1 (de) 2002-04-15
JPH11506416A (ja) 1999-06-08
DE69607749T2 (de) 2000-07-27
BR9607410A (pt) 1998-07-07

Similar Documents

Publication Publication Date Title
PT809512E (pt) Solucoes farmaceuticas salinas nao inorganicas para administracao endonasal de uma calcitonina
JP3527890B2 (ja) フマル酸アルキル水素エステルからなる乾癬、乾癬性関節炎、神経皮膚炎および限局性回腸炎クローン病の治療剤
ES2173096T3 (es) Composicion farmaceutica peletizada.
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
FR2651677B1 (fr) Composition pharmaceutique a base de salmeterol et du propionate de fluticasone.
CY1110801T1 (el) Μεθοδοι και συνθεσεις για την προληψη και θεραπεια της αναιμιας
ATE332138T1 (de) Flibanserin zur behandlung extrapyramidaler bewegungsstörungen
NO941276L (no) Lipofile, oligosakkaride antibiotikasaltpreparater
DE69002718D1 (de) Medikamente.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
RU94045140A (ru) Фармацевтическая композиция для профилактики или лечения вирусных заболеваний, способ ее получения и применение антагониста брадикинина или его физиологически переносимой соли в качестве средства для профилактики или лечения вирусных заболеваний
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
IL57513A0 (en) 1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them
AR002040A1 (es) Soluciones farmacéuticas salinas no inorgánicas para administración endonasal conteniendo una calcitonina natural o modificada y excipientes orgánicos.
SE8502039L (sv) Nya lekemedelskompositioner med antimikrobiell aktivitet och forfarande for deras framstellning
MX9605633A (es) Composicion farmaceutica, metodo y dispositivo para prevenir o tratar resequedad de los ojos o enfermedad ocasionada por la misma.
ECSP961663A (es) Soluciones salinas no inorganicas para administracion endonasal
RU93047670A (ru) Соединения общей формулы, способы их получения, фармацевтическая композиция и пестициды на их основе
TH43276A (pt)